Search Results | MSF Science Portal

Journal Article

|

Letter

Al-Rabeeah AA, Ebrahim SH, Mwamba D, Ditekemena J, Christou C, et al.

2025-04-04 • Lancet Infectious Diseases

Journal Article

|

Research

Nesbitt RC, Kinya Asilaza V, Alvarez C, Gitahi P, Nkemenang P, et al.

2025-01-08 • Lancet Infectious Diseases

BACKGROUND

Hepatitis E virus (HEV) is a leading cause of acute viral hepatitis, particularly in Asia and Africa, where HEV genotypes 1 and 2 are prevalen...

Journal Article

|

Research

Coldiron ME, Soumana I, Baudin E, Langendorf C, Mamiafo Tchoula C, et al.

2025-01-08 • Lancet Infectious Diseases

BACKGROUND

In settings with low pneumococcal conjugate vaccine (PCV) coverage, multi-age cohort mass campaigns could increase population immunity, and fractiona...

Journal Article

|

Review

Rojek A, Fieggen J, Paterson A, Byakika-Kibwika P, Camara M, et al.

2024-12-12 • Lancet Infectious Diseases

Journal Article

|

Review

Rojek A, Fieggen J, Apiyo P, Caluwaerts S, Fowler RA, et al.

2024-12-01 • Lancet Infectious Diseases

The west Africa Ebola disease epidemic (2014-16) marked a historic change of course for patient care during emerging infectious disease outbreaks. The epidemic response was a failure ...

Journal Article

|

Research

Elsinga J, Sunyoto T, di Stefano L, Giorgetti PF, Kyi HA, et al.

2024-09-01 • Lancet Infectious Diseases

BACKGROUND
Lassa fever is a viral haemorrhagic fever with few options for diagnosis and treatment; it is also under-researched with knowledge gaps on its epidemiology. A point-of-car...

Journal Article

|

Case Report/Series

Meakin S, Nsio J, Camacho A, Kitenge R, Coulborn RM, et al.

2024-08-01 • Lancet Infectious Diseases

BACKRGOUND

The rec...

Journal Article

|

Commentary

Juan-Giner A, Warimwe GM

2024-06-01 • Lancet Infectious Diseases

Journal Article

|

Letter

Finger F, Heitzinger K, Berendes D, Ciglenecki I, Dominguez M, et al.

2024-04-30 • Lancet Infectious Diseases

Journal Article

|

Research

Coulborn RM, Bastard M, Peyraud N, Gignoux EM, Luquero FJ, et al.

2024-02-01 • Lancet Infectious Diseases

BACKGROUND
The rVSVΔG-ZEBOV-GP vaccine constitutes a valuable tool to control Ebola virus disease outbreaks. This retrospective cohort study aimed to assess the protective effect of ...

Journal Article

|

Review

van Griensven J, Dorlo TPC, Diro EGJ, Costa CH, Burza S

2024-01-01 • Lancet Infectious Diseases

For the past 15 years, trials of combination therapy options for visceral leishmaniasis have been conducted with the aim of identifying effective, and safe treatment regimens that were s...

Journal Article

|

Commentary

Kofman AD, Haberling DL, Mbuyi G, Martel LD, Whitesell AN, et al.

2023-08-18 • Lancet Infectious Diseases

Journal Article

|

Research

Juan-Giner A, Namulwana ML, Kimathi D, Grantz KH, Fall G, et al.

2023-04-28 • Lancet Infectious Diseases

BACKGROUND
Current supply shortages constrain yellow fever vaccination activities, particularly outbreak response. Although fractional doses of all WHO-prequalified yellow fever vacc...

Journal Article

|

Commentary

Chowdhury M, Ouma J, Nakabembe E, Mwanga-Amumpaire J, Kirenga B, et al.

2023-04-24 • Lancet Infectious Diseases

Journal Article

|

Commentary

Boum Y II, Moukoko CEE, Parikh S

2023-04-01 • Lancet Infectious Diseases

Journal Article

|

Letter

Torreele E, Boum Y, Adjaho I, Alé FGB, Issoufou SH, et al.

2023-04-01 • Lancet Infectious Diseases

Journal Article

|

Research

Marcy O, Wobudeya E, Font H, Vessière A, Chabala C, et al.

2023-03-01 • Lancet Infectious Diseases

BACKGROUND
Tuberculosis diagnosis might be delayed or missed in children with severe pneumonia because this diagnosis is usually only considered in cases of prolonged symptoms or ant...

Journal Article

|

Commentary

Torreele E, Boum Y, Adjaho I, Alé FGB, Issoufou SH, et al.

2023-01-19 • Lancet Infectious Diseases

Three years since proving effective for Ebola virus disease in a clinical trial, two breakthrough treatments are registered and stockpiled in the USA but still not registered and general...

Journal Article

|

Research

Nsio JM, Ardiet DL, Coulborn RM, Grellety E, Albela M, et al.

2023-01-01 • Lancet Infectious Diseases

BACKGROUND
In its earliest phases, Ebola virus disease's rapid-onset, high fever, and gastrointestinal symptoms are largely indistinguishable from other infectious illnesses. We aime...

Journal Article

|

Letter

Ciglenecki I, Rumunu J, Wamala JF, Nkemenang P, Duncker J, et al.

2022-08-01 • Lancet Infectious Diseases

Science Portal

DR Congo's conflict and cholera: a call for ring vaccination

The effectiveness of two doses of recombinant hepatitis E vaccine in response to an outbreak in Bentiu, South Sudan: a case–control and bias indicator study

Effect of mass campaigns with full and fractional doses of pneumococcal conjugate vaccine (Pneumosil) on the reduction of nasopharyngeal pneumococcal carriage in Niger: a three-arm, open-label, cluster-randomised trial

Embedding treatment in stronger care systems

Ebola disease: Bridging scientific discoveries and clinical application

Field evaluation of validity and feasibility of Pan-Lassa rapid diagnostic test for Lassa fever in Abakaliki, Nigeria: a prospective diagnostic accuracy study

Effectiveness of rVSV-ZEBOV vaccination during the 2018–20 Ebola virus disease epidemic in the Democratic Republic of the Congo: a retrospective test-negative study

Accumulating evidence on the long-term immunogenicity of fractional dosing for yellow fever vaccines

Reporting of deaths during cholera outbreaks: case fatality ratio and community deaths

Case fatality risk among individuals vaccinated with rVSVΔG-ZEBOV-GP: a retrospective cohort analysis of patients with confirmed Ebola virus disease in the Democratic Republic of the Congo

The status of combination therapy for visceral leishmaniasis: an updated review

Revisiting the minimum incubation period of Zaire ebolavirus

Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

Strengthening the maternal and child health responses to Ebola outbreaks in Uganda

Moving towards malaria elimination with safer treatment for children with G6PD deficiency

On the importance and challenges of global access to proven life-saving treatments for Ebolavirus – Authors' reply

Effect of systematic tuberculosis detection on mortality in young children with severe pneumonia in countries with high incidence of tuberculosis: a stepped-wedge cluster-randomised trial

Breakthrough treatments for Ebola virus disease, but no access—what went wrong, and how can we do better?

Differential symptomology of possible and confirmed Ebola virus disease infection in the Democratic Republic of the Congo: a retrospective cohort study

The first reactive vaccination campaign against hepatitis E